ASX listed company, Safety Medical Products Limited (ASX: SFP)(SafetyMed), announced today it had been granted approval by the Federal Department of Health to supply the first ever Australian made retractable syringes to the National Diabetes Services Scheme (NDSS).
Ventracor (ASX: VCR) has implanted the 200th patient with its VentrAssist(tm) Left Ventricular Assist Device (LVAD)
Eastland Medical Systems Ltd (ASX: EMS) remains on track with the development of its anti-malaria treatment ArTiMistTM and will commence a multi dose Phase 1 clinical trial for ArTiMistTM in February, after its Pharmaceutical Division receiving approval from the South African MCC Regulatory Body.
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) wishes to advise of its progress in licensing its core intellectual property pertaining to non-coding DNA.
Occupational & Medical Innovations Limited (ASX: OMI) today announced the receipt of its opening US sales order from its leading North American distributor for the auto retractable safety syringe.
Eastland Medical Systems (ASX EMS) is looking to significantly increase revenues in 2008 as a result of its decision to concentrate on the development of its Pharmaceutical Division - with fast-track low-risk pharmaceutical development and early market entry of pharmaceutical product.
Ventracor (ASX: VCR) today announced CE Marking approval for the next version of the VentrAssist(tm) left ventricular assist device (LVAD) which allows it to be marketed and sold in Europe.
